Quipt sees 2025 as ‘pivotal year’ 

CINCINNATI – Quipt Home Medical plans to return to historical levels of organic growth, optimize capital allocation and build a scalable health care ecosystem through M&A as part of a new strategic plan. 

The plan follows the company’s annual general meeting of shareholders on March 17. 

“2025 marks a pivotal year for Quipt as we double down on our commitment to augment organic growth and prioritize a disciplined capital allocation strategy while maintaining strong margins,” said Gregory Crawford, CEO and chairman of Quipt. “We are also dedicated to strategically deploying capital through targeted share repurchases aimed at maximizing shareholder value, while adopting a refined approach to our historical M&A strategy. By aligning with healthcare systems through potential joint ventures and strategic acquisitions, we see a significant and scalable opportunity to accelerate growth and position Quipt as a leader in integrated home-based care. With a focus on improving operational efficiencies, expanding de novo locations into favorable markets, and strengthening our referral pipeline, we are well-positioned to deliver long-term value.” 

Quipt says it’s working to accelerate organic growth by expanding its de novo footprint, deepening referral networks and enhancing operational efficiencies to sustain strong and consistent margins. Key initiatives include: 

• Expansion of de novo locations: Following the successful opening of two locations in Florida and Alabama, Quipt plans additional site launches in high-value, strategic markets to strengthen its national presence. 
• Deepening referral networks: The company is reinforcing relationships with physicians, hospitals and health care providers in an effort to drive patient acquisition and enhance long-term referral pipelines. 
• Sales force growth & training: Quipt is adding new sales representatives in targeted regions while launching the Quipt Sales Accelerator program, an initiative focused on advanced sales education and performance-driven training. 
• Operational efficiencies to protect margins: Through optimized intake processes, streamlined sales operations and improved service delivery, the company remains committed to preserving strong, consistent margins while delivering exceptional patient care. 
• Product portfolio expansion: Quipt has been and continues to introduce new respiratory product offerings, including a recently Medicare-approved device, which enhances airway clearance and secretion mobilization, which fits seamlessly into the company’s strategy of serving higher-acuity respiratory patients. 

Quipt says capital allocation also remains a top priority as it takes an aggressive approach to enhance shareholder value through active share repurchases and an expanded M&A strategy. Key initiatives include: 

• Share repurchase program: The company plans to execute on its normal course issuer bid (NCIB) in the coming months, reflecting its confidence in its strong underlying fundamentals and commitment to delivering enhanced value to shareholders. The company believes that its common shares continue to be undervalued in the market. 
• Strategic M&A with healthcare systems: Quipt is expanding its historical focus beyond acquiring only traditional DME providers. The company is currently in active discussions to align with health care systems through potential joint venture or strategic acquisition. These opportunities could come with a preferred provider agreement, which presents the company with significant, untapped growth opportunities to integrate home-based care within larger healthcare ecosystems. 
• Building a scalable playbook for health system partnerships: The company has begun identifying key health care system partners in priority markets, targeting those with established patient bases and aligned objectives, such as reducing hospital readmissions and improving post-acute care. By combining Quipt’s expertise in operational efficiency and clinical excellence with health systems localized patient flow and market knowledge, the Company aims to deepen its geographic reach and provide innovative home healthcare solutions. 
• A replicable growth model: The company’s joint venture strategy will serve as a scalable model for potential future partnerships to enable Quipt to expand nationally while strengthening its role as a trusted, value-adding partner in the broader health care landscape. 

Related: Quipt says ‘We’ve got a lot of levers that we’re pulling.’ 

Related: Quipt, Kanen announces cooperative agreement.